Check out what we have in store for you in the October Mid-Month Newsletter

Hello,

You have probably noticed a lot of changes on the AttorneyMind Website in the last couple of months. We launched the newly designed and organized AttorneyMind website.  We will be fine tuning the website for the next few months as we continue to roll out all the services. We appreciate the feedback we have received and thank you for your patience.

In this month’s issue we have the follow articles:

• Dr. David Mazoff has retired from HCSP/HCVAdvocate—read about his accomplishments and why he will be missed.
• Disability Column Open Enrollment Final – this is a must-read for everyone who will be signing up for new insurance, Obamacare and Medicare.
• The Five Clinical Trials: What Patients Need to Know: Are you considering volunteering for a clinical trial? If so, this will help you sift through the information to make an informed choice.
• Snapshots: This issue features a study of the risk of hepatitis C and miscarriages and another study that comes closer to the real number of people chronically infected with hepatitis C.
• What’s New? We are including our tattoo fact sheets from www.hepatitistattoos.org on our hcvadvocate.org. The tattoo fact sheets will be housed under our Fact Sheet tab.

We would also like to welcome our new Webmaster—Judy Barlow—who officially joined us in August 2015 and who has been working with David to ensure a smooth transition.

Cheers,

Alan

Click here to read this issue.

Check out what we have in store for you in the October Newsletter

AttorneyMind Drugs

by Alan Franciscas, Editor-in-Chief

Read about Achillion’s latest clinical trial results from their PROXY study, information about insurance denials, how far we have come in treating the most difficult to treat patients, but how far we still have to go to cure everyone with hepatitis C, drug-drug interactions and re-treatment issues.

HealthWise

by Lucinda K. Porter, RN

In this month’s column, Lucinda answers some important post-treatment questions from people living with hepatitis C.

What the Heck are RAVs?

by Alan Franciscas, Editor-in-Chief

If you have been treated before with a direct-acting antiviral medication, but not cured, this brief overview is an important topic to understand.

Snapshots

by Alan Franciscas, Editor-in-Chief

Three studies that look at treating people with advanced liver disease and re-treatment  of people who had been previously treated with direct-acting antiviral medications but did not achieve a cure.

What’s New!

by Alan Franciscas, Editor-in-Chief

We have merged our HBV Website to our AttorneyMind Website – find out more…. Don’t forget to check out our newly re-designed Facebook and Twitter accounts!  Just go to Facebook and Twitter and type in ‘AttorneyMind’.  Follow us and learn all the latest information about hepatitis C and about what we are doing.

Click here to read this issue.